{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:53:22Z","timestamp":1778075602077,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1124\/dmd.111.040691","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T02:42:47Z","timestamp":1319856167000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacokinetics of Lisdexamfetamine Dimesylate after Targeted Gastrointestinal Release or Oral Administration in Healthy Adults"],"prefix":"10.1016","volume":"40","author":[{"given":"James C.","family":"Ermer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Haffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Doll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik P.","family":"Sandefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Trespidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.111.040691_bib1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","article-title":"Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"69","author":"Adler","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clinthera.2010.02.011","volume":"32","author":"Boellner","year":"2010","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.111.040691_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0928-0987(01)00132-4","article-title":"A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide-simethicone formulation in man","volume":"13","author":"Connor","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.111.040691_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF00175865","article-title":"Gamma scintigraphy in the evaluation of pharmaceutical dosage forms","volume":"19","author":"Davis","year":"1992","journal-title":"Eur J Nucl Med"},{"key":"10.1124\/dmd.111.040691_bib5","first-page":"309","article-title":"Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms","volume":"7","author":"Digenis","year":"1991","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1124\/dmd.111.040691_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11588190-000000000-00000","article-title":"Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men","volume":"31","author":"Ermer","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1124\/dmd.111.040691_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/0091270009357346","article-title":"Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers","volume":"50","author":"Ermer","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.111.040691_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1185\/030079907X182095","article-title":"Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release","volume":"23","author":"Ermer","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/dmd.111.040691_bib9","series-title":"Poster presented at the 160th Annual Meeting of the American Psychiatric Association; 2007 May 19\u201324; San Diego, CA.","article-title":"Improved interpatient pharmacokinetic variability of lisdexamfetamine dimesylate compared with mixed amphetamine salts extended release in children aged 6 to 12 years with attention-deficit\/hyperactivity disorder","author":"Ermer","year":"2007"},{"key":"10.1124\/dmd.111.040691_bib10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1360-0443.1991.tb01754.x","article-title":"Pharmacokinetic considerations in abuse liability evaluation","volume":"86","author":"Farr\u00e9","year":"1991","journal-title":"Br J Addict"},{"key":"10.1124\/dmd.111.040691_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaac.2011.01.007","article-title":"Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit\/hyperactivity disorder","volume":"50","author":"Findling","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1017\/S1092852900016898","article-title":"Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit\/hyperactivity disorder","volume":"13","author":"Findling","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1124\/dmd.111.040691_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/cap.2008.0165","article-title":"Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit\/hyperactivity disorder: an open-label, dose-optimization study","volume":"19","author":"Findling","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1124\/dmd.111.040691_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-199936030-00004","article-title":"Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications","volume":"36","author":"Fleisher","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.111.040691_bib15","first-page":"39","article-title":"Lisdexamfetamine dimesylate: the first prodrug stimulant","volume":"4","author":"Goodman","year":"2007","journal-title":"Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3810\/pgm.2009.09.2048","article-title":"Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults","volume":"121","author":"Haffey","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1124\/dmd.111.040691_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1990.tb03740.x","article-title":"Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule","volume":"30","author":"Harder","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.111.040691_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.v61n0604","article-title":"Low-dose amphetamine salts and adult attention-deficit\/hyperactivity disorder","volume":"61","author":"Horrigan","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/dmd.106.011973","article-title":"An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes","volume":"35","author":"Krishnan","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040691_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0091270007310381","article-title":"Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study","volume":"48","author":"Krishnan","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.111.040691_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/138920007779816002","article-title":"Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy","volume":"8","author":"Lin","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.111.040691_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10611869409015908","article-title":"In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration","volume":"2","author":"Meseguer","year":"1994","journal-title":"J Drug Target"},{"key":"10.1124\/dmd.111.040691_bib23","series-title":"Poster presented at the Institute on Psychiatric Services 58th Annual Meeting; 2006 Oct 5\u20138; New York, NY.","article-title":"Pharmacokinetics of NRP 104 (lisdexamfetamine dimesylate) following administration of a single intranasal, intravenous, or oral dose in rats","author":"Moncrief","year":"2006"},{"key":"10.1124\/dmd.111.040691_bib24","unstructured":"National Council on Radiation Protection and Measurements (1993) Limitation of Exposure to Ionizing Radiation. NCRPM Report No. 116. Bethesda, MD."},{"key":"10.1124\/dmd.111.040691_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1018884510163","article-title":"Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog","volume":"16","author":"Parr","year":"1999","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.111.040691_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","article-title":"Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine","volume":"6","author":"Pennick","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/dmd.111.040691_bib27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1023\/A:1011910223812","article-title":"Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract","volume":"15","author":"Pithavala","year":"1998","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.111.040691_bib28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","article-title":"The Texas Children\u2019s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder","volume":"45","author":"Pliszka","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib29","series-title":"Applications of Pharmacokinetic Principles in Drug Development","first-page":"182","article-title":"Human drug absorption studies in early development","author":"Prior","year":"2004"},{"key":"10.1124\/dmd.111.040691_bib30","first-page":"8","article-title":"Therapeutic relevance of pharmacokinetics and pharmacodynamics","volume":"19","author":"Ratain","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1124\/dmd.111.040691_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/0016-5085(83)90382-7","article-title":"Effect of gastrointestinal intubation on the passage of a solid meal through the stomach and small intestine in humans","volume":"84","author":"Read","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.111.040691_bib32","series-title":"Applied Biopharmaceutics & Pharmacokinetics","first-page":"371","article-title":"Physiologic factors related to drug absorption","author":"Shargel","year":"2005"},{"key":"10.1124\/dmd.111.040691_bib33","series-title":"Poster presented at the 160th Annual Meeting of the American Psychiatric Association; 2007 May 19\u201324; San Diego, CA.","article-title":"Lisdexamfetamine dimesylate as a treatment for ADHD: dosage formulation and pH effects","author":"Shojaei","year":"2007"},{"key":"10.1124\/dmd.111.040691_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.163.3.387","article-title":"PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate","volume":"163","author":"Spencer","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clinthera.2006.02.011","article-title":"Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit\/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study","volume":"28","author":"Spencer","year":"2006","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.111.040691_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF00608217","article-title":"Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device","volume":"30","author":"Staib","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.111.040691_bib37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.5414\/CPP45662","article-title":"Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man","volume":"45","author":"Tuerck","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/dmd.111.040691_bib38","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","article-title":"Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD","volume":"160","author":"Volkow","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1124\/dmd.111.040691_bib39","series-title":"Vyvanse (package insert)","year":"2011"},{"key":"10.1124\/dmd.111.040691_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S1092852900024056","article-title":"Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"14","author":"Weisler","year":"2009","journal-title":"CNS Spectr"},{"key":"10.1124\/dmd.111.040691_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1744-9081-6-34","article-title":"Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: novel findings using a simulated adult workplace environment design","volume":"6","author":"Wigal","year":"2010","journal-title":"Behav Brain Funct"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624226143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624226143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.111.040691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:05:52Z","timestamp":1739909152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624226143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0090955624226143"],"URL":"https:\/\/doi.org\/10.1124\/dmd.111.040691","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of Lisdexamfetamine Dimesylate after Targeted Gastrointestinal Release or Oral Administration in Healthy Adults","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.111.040691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}